High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Items 201–300 of 865
Boyce, M., Warrington, S., Cortezi, B., Zöllner, S., Vauléon, S., Swinkels, D. W., Summo, L., Schwoebel, F., & Riecke, K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13433 · Cited by 82
“Hepcidin expression is inhibited by erythropoietic activity through certain factors such as growth differentiation factor 15 (Tanno et al., 2007), twisted gastrulation protein homologue 1 (Tanno et al.”
Multibiomarker analysis in patients with acute myocardial infarction
Schernthaner, C., Lichtenauer, M., Wernly, B., Paar, V., Pistulli, R., Rohm, I., Jung, C., Figulla, H., Yilmaz, A., Cadamuro, J., et al. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12785 · Cited by 85
Genetic mechanisms and modifying factors in hereditary hemochromatosis
Weiss, G. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.201 · Cited by 82
“Polymorphisms in genes involved in hematopoiesis, such as GDF15”
BackgroundDiagnosis of iron-deficient states
Archer, N. M., & Brugnara, C. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1038744 · Cited by 82
β-Thalassemia intermedia: a comprehensive overview and novel approaches
Asadov, C. D., Alimirzoyeva, Z., Mammadova, T., Aliyeva, G., Gafarova, S., & Mammadov, J. (2018) · International Journal of Hematology · doi:10.1007/s12185-018-2411-9 · Cited by 94
“The suppressed levels of hepcidin can also be due to the effect of growth differentiation factor 15 (GDF15), which eventually ends in decreased duodenal iron absorption and the systemic iron overload [25].”
BackgroundGrowth-Differentiation Factor-15 in Heart Failure
Kempf, T., & Wollert, K. C. (2009) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.04.006 · Cited by 86
Zumbrennen‐Bullough, K. B., & Babitt, J. L. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft443 · Cited by 92
“TGF-β/BMP superfamily modulators GDF15 and TWSG1 have been proposed to mediate hepcidin suppression in iron loading anemias with ineffective erythropoiesis such as β-thalassemia [78, 79], but may not mediate hepcidin suppression in other contexts [80, 81].”
BackgroundIron overload in thalassaemia intermedia: reassessment of iron chelation strategies
Taher, A. T., Hershko, C., & Cappellini, M. D. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07848.x · Cited by 81
“…of hepcidin production: growth differentiation factor 15 (GDF15), secreted by erythroid precursors that are greatly expanded in thalassaemia (Tanno et al, 2007), and hypoxiainducible transcription factors (HIFs) that control iron homeostasis by downregulating hepcidin production in response…”
BackgroundIron Homeostasis and Its Interaction with Prolyl Hydroxylases
Mole, D. R. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2790 · Cited by 82
“Growth and differentiation factor 15 (GDF15), an iron- and oxygen-regulated (75) member of the TGF-b superfamily of proteins that includes all BMPs, exhibits increased expression and secretion during erythroblast maturation and inhibits hepcidin expression in vitro (140).”
Recent advances in the understanding of inherited sideroblastic anaemia
Camaschella, C. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07290.x · Cited by 87
“The serum level of growth differentiation factor 15, a candidate suppressor of hepcidin in thalassemia (Tanno et al, 2007) was not measured in this condition.”
BackgroundHepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
Swinkels, D. W., & Wetzels, J. F. M. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn267 · Cited by 80
“The relationship between hepcidin production and erythropoiesis suggests the presence of a regulator between the erythron and the liver, and several candidates for this role have been proposed, for example the soluble transferrin receptor (sTfR) [14,15] and the growth differentiation factor (GDF)-15 [16].”
BackgroundIron overload in hematological disorders
Fibach, E., & Rachmilewitz, E. A. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.007 · Cited by 88
“It was demonstrated to suppress hepcidin mRNA expression in hepatocyte culture [43] (B) The soluble transferrin receptor— In various forms of erythropoietic dysfunction, including ineffective erythropoiesis, hepcidin deficiency was only found when high levels of GDF-15 were associated with high levels of the soluble t…”
BackgroundTreating iron overload in patients with non‐transfusion‐dependent thalassemia
Taher, A. T., Viprakasit, V., Musallam, K. M., & Cappellini, M. D. (2013) · American Journal of Hematology · doi:10.1002/ajh.23405 · Cited by 83
“In NTDT, downregulation of hepcidin is mediated by extensive erythropoiesis as well as chronic anemia [38], hypoxia [38], as well as growth differentiation factor-15 (GDF-15) [39,40] and twisted gastrulation factor [41].”
BackgroundIron metabolism in thalassemia and sickle cell disease
Mariani, R., Trombini, P., Matteo Pozzi, & Piperno, A. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.006 · Cited by 84
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice
Bartnikas, T. B., Andrews, N. C., & Fleming, M. D. (2011) · Blood · doi:10.1182/blood-2010-05-287359 · Cited by 77
Roetto, A., Di Cunto, F., Pellegrino, R. M., Hirsch, E., Azzolino, O., Bondi, A., Defilippi, I., Carturan, S., Miniscalco, B., Riondato, F., et al. (2010) · Blood · doi:10.1182/blood-2009-09-240960 · Cited by 74
-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
Melchiori, L., Gardenghi, S., & Rivella, S. (2010) · Advances in Hematology · doi:10.1155/2010/938640 · Cited by 74
“Since high levels of ID1 have been found to inhibit cell differentiation, its up-regulation due to a sustained activation of Jak2 by EPO in β-thalassemia could explain the less mature erythroid progenitors observed.”
Theurl, I., Schroll, A., Nairz, M., Seifert, M., Theurl, M., Sonnweber, T., Kulaksiz, H., & Weiss, G. (2011) · Haematologica · doi:10.3324/haematol.2011.048926 · Cited by 76
“7 In addition to iron and inflammation, the expression of hepcidin is controlled by hypoxia, endoplasmatic reticulum stress, erythropoietic activity and erythropoiesis driven signals (25, 35-40).”
BackgroundRational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease
Nielsen, O., Soendergaard, C., Vikner, M., & Weiss, G. (2018) · Nutrients · doi:10.3390/nu10010082 · Cited by 76
New Insights Into Pathophysiology of β-Thalassemia
Sánchez‐Villalobos, M., Blanquer, M., Moraleda, J. M., Salido, E. J., & Pérez‐Oliva, A. B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.880752 · Cited by 76
“This is a member of the transforming growth factor- (TGF-β) family which use to be upregulated during ineffective erythropoiesis, causing the down regulation of hepcidin (14).”
BackgroundKahli, A., Guénancia, C., Zeller, M., Grosjean, S. A., Stamboul, K., Rochette, L., Girard, C., & Vergely, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105759 · Cited by 79
“GDF-15 is known to be implicated in dyserythropoietic syndromes such as thalassemia or sickle cell disease[37].”
BackgroundMleczko-Sanecka, K., Roche, F., Rita da Silva, A., Call, D., D’Alessio, F., Ragab, A., Lapinski, P. E., Ummanni, R., Korf, U., Oakes, C., et al. (2014) · Blood · doi:10.1182/blood-2013-07-515957 · Cited by 74
“In addition, several mechanisms of hepcidin suppression have been identified and involve either the protease TMPRSS6 (matriptase-2),(15,27,28) the inhibitory SMAD7,(29) stabilization of hypoxia-inducible factor,(30) erythropoietin,(31) or 2 soluble factors of the transforming growth factor-b family, growth differentia…”
BackgroundPathomechanisms of Immunological Disturbances in β-Thalassemia
Gluba-Brzózka, A., Franczyk, B., Rysz-Górzyńska, M., Rokicki, R., Koziarska-Rościszewska, M., & Rysz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189677 · Cited by 89
“Iron overload in thalassemia syndromes was also found to be associated with growth differentiation factor 15 (GDF15) overexpression related to an expanded erythroid compartment and the inhibition of hepcidin expression [74].”
BackgroundBehavioral, biochemical, and genetic analysis of iron metabolism in high‐intensity blood donors
Mast, A. E., Foster, T. M., Pinder, H. L., Beczkiewicz, C. A., Bellissimo, D. B., Murphy, A. T., Kovacevic, S., Wroblewski, V. J., & Witcher, D. R. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01823.x · Cited by 75
“GDF15 produced by maturing erythroblasts down regulates hepcidin production by the liver causing increased iron absorption from the gastrointestinal tract.(6) Because superdonors have very low serum hepcidin levels and have an expanded erythroid compartment necessary to replace the RBCs lost through blood donation, we…”
BackgroundInfluentialThe Treatment of Secondary Hemochromatosis
Gattermann, N. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0499 · Cited by 76
Arezes, J., Foy, N., McHugh, K., Quinkert, D., Benard, S., Sawant, A., Frost, J. N., Armitage, A. E., Pasricha, S.-R., Lim, P. J., et al. (2020) · Blood · doi:10.1182/blood.2019003140 · Cited by 68
Porter, J. B. (2009) · Hemoglobin · doi:10.3109/03630260903346627 · Cited by 73
“Growth differentiation factor 15 (GDF15) derived from red cell progenitors suppresses hepcidin synthesis and is present at increased plasma concentrations in the presence of IE (55).”
BackgroundTheurl, I., Finkenstedt, A., Schroll, A., Nairz, M., Sonnweber, T., Bellmann‐Weiler, R., Theurl, M., Seifert, M., Wroblewski, V. J., Murphy, A. T., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07961.x · Cited by 72
“…hormone, growth differentiation factor-15 (GDF15), which is strongly increased in b-thalassaemia and congenital dyserythropoietic anaemia, blocks hepcidin expression and increases iron absorption thus leading to iron loading in these anaemias (Tanno et al, 2007; Tamary et al, 2008).”
BackgroundResultInfluentialDecreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice
Li, H., Choesang, T., Bao, W., Chen, H., Feola, M., Garcia-Santos, D., Li, J., Sun, S., Follenzi, A., Pham, P., et al. (2017) · Blood · doi:10.1182/blood-2016-09-742387 · Cited by 71
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.006 · Cited by 74
Iron homeostasis: new players, newer insights
Edison, E. S., Bajel, A. R., & Chandy, M. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01143.x · Cited by 89
“Erythropoietic demand suppresses hepcidin expression and GDF 15 is thought to play a key role in this (15).”
BackgroundAdvances in understanding the mechanisms of erythropoiesis in homeostasis and disease
Liang, R. H.-S., & Ghaffari, S. (2016) · British Journal of Haematology · doi:10.1111/bjh.14194 · Cited by 74
Zimmermann, M. B., Fucharoen, S., Winichagoon, P., Sirankapracha, P., Zeder, C., Gowachirapant, S., Judprasong, K., Tanno, T., Miller, J. L., & Hurrell, R. F. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.1026 · Cited by 69
“Compared with the concentration in control subjects, The concentrations of serum GDF-15 in persons with -thalassemia syndromes is 100fold those in control subjects, but they are not significantly higher in heterozygotes for - and -thalassemia (40).”
BackgroundSelf-citationIron and liver cancer: an inseparable connection
Hino, K., Yanatori, I., Hara, Y., & Nishina, S. (2021) · FEBS Journal · doi:10.1111/febs.16208 · Cited by 75
Role of growth differentiation factor 15 in cancer cachexia (Review)
Ling, T., Zhang, J., Ding, F., & Ma, L. (2023) · Oncology Letters · doi:10.3892/ol.2023.14049 · Cited by 72
“Additionally, GDF15 is produced by erythroid precursor cells, and high levels of GDF15 are known to inhibit effective erythropoiesis and the expression of hepcidin, leading to anemia and iron overload (61).”
BackgroundWaalen, J., von Löhneysen, K., Lee, P. L., Xu, X., & Friedman, J. S. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01631.x · Cited by 73
“Very high levels of GDF15 have been reported to suppress hepcidin production (22), but there is no evidence that the modestly increased GDF15 levels found in the present study have such an effect.”
BackgroundMethodThalassemia: An Overview of 50 Years of Clinical Research
Sankaran, V. G., & Nathan, D. G. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.009 · Cited by 80
What can we learn from ineffective erythropoiesis in thalassemia?
Oikonomidou, P. R., & Rivella, S. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.10.001 · Cited by 79
Roghi, A., Cappellini, M. D., Wood, J. C., Musallam, K. M., Pedrotti, P., Fasulo, M. R., Cesaretti, C., & Taher, A. T. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0879-3 · Cited by 68
“In TI, the combination of ineffective erythropoiesis and chronic anemia/hypoxia results in hepcidin suppression, increased intestinal iron absorption, and increased release of recycled iron from the reticuloendothelial (RE) system (macrophages) to the hepatocytes [1, 13, 14].”
BackgroundHaemochromatosis: The bone and the joint
Guggenbuhl, P., Brissot, P., & Loréal, O. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.014 · Cited by 69
Known and potential roles of transferrin in iron biology
Bartnikas, T. B. (2012) · BioMetals · doi:10.1007/s10534-012-9520-3 · Cited by 63
“signaling antagonists Gdf15 (Tanno et al. 2007), Twsg1 (Tanno et al.”
Ironing Out the Wrinkles in Host Defense: Interactions between Iron Homeostasis and Innate Immunity
Wang, L., & Cherayil, B. J. (2009) · Journal of Innate Immunity · doi:10.1159/000210016 · Cited by 64
“Siderocalin may also have functions independent of its ability to sequester bacterial siderophores. In the unliganded state, it has been reported to reduce intracellular free iron by unclear mechanisms, while in certain situations it may actually deliver iron to cells [ , , , ,”
BackgroundKawabata, H. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2365-3 · Cited by 68
Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis
Reyes, J., & Yap, G. S. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200641 · Cited by 65
Kannengiesser, C., Sánchez, M., Sweeney, M. C., Hetet, G., Kerr, B. C., Moran, E., Soler, J. L. F., Maloum, K., Matthes, T., Oudot, C., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.039164 · Cited by 66
“It is thought that the cause of this iron overload is repression of hepcidin expression produced by an expanded but ineffective erythropoiesis.(9,10) In addition, all patients became rapidly transfusion-dependent so that regular monitoring of iron levels and iron chelation therapy to prevent complications of secondary…”
BackgroundMolecular basis of iron-loading disorders
Darshan, D., Frazer, D. M., & Anderson, G. J. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001687 · Cited by 64
Wu, Q., Jiang, D., & Chu, H. W. (2012) · Innate Immunity · doi:10.1177/1753425911429837 · Cited by 63
Blanchette-Farra, N., Kita, D., Konstorum, A., Tesfay, L., Lemler, D., Hegde, P., Claffey, K. P., Torti, F. M., & Torti, S. V. (2018) · Oncogene · doi:10.1038/s41388-018-0243-y · Cited by 62
“the response of hepatocyte cells to GDF-15 in vitro was shown to be biphasic, with lower levels of GDF-15stimulating hepcidin synthesis, and higher levels (≥10,000 pg/ml) inhibiting hepcidin [44].”
BackgroundSerum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation
Kanda, J., Mizumoto, C., Kawabata, H., Tsuchida, H., Tomosugi, N., Matsuo, K., & Uchiyama, T. (2008) · Haematologica · doi:10.3324/haematol.12399 · Cited by 66
“Recently, growth differentiation factor-15 (GDF-15), a member of the transforming growth factor-β superfamily, was proposed to be one such factor in β-thalassemia patients.(15) However, to date, most information regarding such putative hepcidin regulators have been derived from animal experiments or in vitro studies w…”
BackgroundGelderman, M. P., Baek, J. H., Yalamanoglu, A., Puglia, M., Vallelian, F., Burla, B., Vostal, J., Schaer, D. J., & Buehler, P. W. (2015) · Haematologica · doi:10.3324/haematol.2014.117325 · Cited by 63
“Furthermore, other iron regulatory hormones, such as the erythroid-derived hepcidin suppressor growth differentiation factor 15 (Gdf15), may be regulated by apoTf either directly via signaling through erythoid TfR2 or indirectly via normalization of ineffective erythropoiesis.(47) In conclusion, we suggest that apoTf…”
BackgroundTherapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
Hawula, Z. J., Wallace, D. F., Subramaniam, V. N., & Rishi, G. (2019) · Pharmaceuticals · doi:10.3390/ph12040170 · Cited by 65
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation factor 1 (TWSG1) are both cytokines produced by erythroblasts which have been found to supress hepcidin expression in human liver cells [42,43].”
BackgroundIron deficiency in critically ill patients: highlighting the role of hepcidin
Heming, N., Montravers, P., & Lasocki, S. (2011) · Critical Care · doi:10.1186/cc9992 · Cited by 71
“Growth differentiation factor 15, a member of the transforming growth factor (TGF)-β family produced by late erythroblasts, has been found in high levels in patients with beta-thalassemia syndromes and has been shown to repress hepcidin synthesis [20].”
Background2017 Clinical trials update in new treatments of β‐thalassemia
Makis, A., Hatzimichael, E., Papassotiriou, I., & Voskaridou, E. (2016) · American Journal of Hematology · doi:10.1002/ajh.24530 · Cited by 59
“4 cycle between inefficient erythropoiesis and increased iron absorption and release [4-9] (Figure 1).”
BackgroundIron Regulatory Hormone Hepcidin Decreases in Chronic Heart Failure Patients With Anemia
Matsumoto, M., Tsujino, T., Lee-Kawabata, M., Naito, Y., Akahori, H., Sakoda, T., Ohyanagi, M., Tomosugi, N., & Masuyama, T. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0663 · Cited by 59
Regulation of vitamin metabolism by p53 and p63 in development and cancer
Zhou, H., & van Bokhoven, H. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12591 · Cited by 61
Hepcidin: A Critical Regulator of Iron Metabolism during Hypoxia
Hintze, K. J., & McClung, J. P. (2011) · Advances in Hematology · doi:10.1155/2011/510304 · Cited by 58
“Growth differentiation factor 15 (GDF15) has been demonstrated to suppress hepcidin expression and is elevated in patients with thalassemia [28].”
BackgroundIron metabolism in athletes – achieving a gold standard
Latunde‐Dada, G. O. (2013) · European Journal of Haematology · doi:10.1111/ejh.12026 · Cited by 55
“GDF15, a positive regulator of serum hepcidin levels (60), was significantly increased immediately post-running the Spartathlon, a 246-km foot-race, an extreme and strenuous form of exercise (61).”
BackgroundDarshan, D., Frazer, D. M., Wilkins, S. J., & Anderson, G. J. (2010) · Haematologica · doi:10.3324/haematol.2010.022426 · Cited by 61
“A soluble form of HJV and inhibitory members of the BMP group, such as GDF15, decrease hepcidin levels, likely by inhibiting various aspects of the BMP/SMAD pathway.(7,14) Other proteins known to be involved in hepcidin regulation are the transmembrane serine protease, matriptase-2 (TMPRSS6), HFE and TfR2.”
BackgroundAmbaglio, I., Malcovati, L., Papaemmanuil, E., Laarakkers, C. M., Della Porta, M. G., Galli, A., Da Via, M. C., Bono, E., Ubezio, M., Travaglino, E., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.077446 · Cited by 59
“Serum ferritin (ng/mL), median (range) 409 (6-8340)”
Musallam, K. M., Taher, A. T., Duca, L., Cesaretti, C., Halawi, R., & Cappellini, M. D. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.07.005 · Cited by 60
Porter, J. B., Cappellini, M. D., Kattamis, A., Viprakasit, V., Musallam, K. M., Zhu, Z., & Taher, A. T. (2017) · British Journal of Haematology · doi:10.1111/bjh.14373 · Cited by 62
Si, Y., Liu, X., Cheng, M., Wang, M., Gong, Q., Yang, Y., Wang, T., & Yang, W. Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019967 · Cited by 60
“GDF15 concentration in human blood is elevated in HCVand HBV-infected patients An increased plasma level of GDF15 has been documented in several human diseases [11,14].”
BackgroundDisorders associated with systemic or local iron overload: from pathophysiology to clinical practice
Sebastiani, G., & Pantopoulos, K. (2011) · Metallomics · doi:10.1039/c1mt00082a · Cited by 57
Thalassaemia Intermedia: an Update
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.004 · Cited by 59
Modulation of hepcidin to treat iron deregulation: potential clinical applications
Blanchette, N. L., Manz, D. H., Torti, F. M., & Torti, S. V. (2016) · Expert Review of Hematology · doi:10.1586/17474086.2016.1124757 · Cited by 59
“secreted by erythroid precursors: likely erythreferrone and/ or growth differentiation factor 15 (GDF15).[22,23] Similar to HH, low hepcidin levels in turn result in excessive iron absorption and an iron overload phenotype.”
BackgroundGenética das doenças hematológicas: as hemoglobinopatias hereditárias
Sonati, M. D. F., & Costa, F. F. (2008) · Jornal de Pediatria · doi:10.1590/s0021-75572008000500007 · Cited by 62
Langer, A. L., & Ginzburg, Y. Z. (2017) · Hemodialysis International · doi:10.1111/hdi.12543 · Cited by 52
Nramp1 equips macrophages for efficient iron recycling
Soe-Lin, S., Sheftel, A. D., Wasyluk, B., & Ponka, P. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.02.013 · Cited by 65
Anemia of Chronic Disease (Anemia of Inflammation)
Agarwal, N., & Prchal, J. T. (2009) · Acta Haematologica · doi:10.1159/000243794 · Cited by 68
“During increased (although ineffective) erythropoiesis in thalassemia intermedia or major, a high level of a cytokine growth differentiation factor 15 (GDF15) inhibits hepcidin expression, contributing to both an increase in iron absorption and iron overload, characteristic of thalassemia [”
BackgroundSuperinfection in malaria: Plasmodium shows its iron will
Portugal, S., Drakesmith, H., & Mota, M. M. (2011) · EMBO reports · doi:10.1038/embor.2011.213 · Cited by 50
Iron overload in myelodysplastic syndromes: A Canadian consensus guideline
Wells, R. A., Leber, B. F., Buckstein, R. J., Lipton, J. H., Hasegawa, W. S., Grewal, K. S., Yee, K. W. L., Olney, H. J., Larratt, L. M., Vickars, L. M., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.02.021 · Cited by 59
New insights into transfusion-related iron toxicity: Implications for the oncologist
Porter, J. B., de Witte, T., Cappellini, M. D., & Gattermann, N. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.11.017 · Cited by 59
“Chronic anemia and ineffective erythropoiesis lead to growth differentiation factor15 overexpression, which inhibits hepcidin production in the liver (Tanno et al., 2007), leading to increased iron absorption from the duodenum (Rishi et al.”
BackgroundPérez-Gómez, M. V., Pizarro-Sánchez, M. S., Gracia-Iguacel, C., Cano, S., Cannata‐Ortiz, P., Sánchez-Rodríguez, J. E., Sanz, A. B., Sánchez-Niño, M. D., & Ortíz, A. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-01020-2 · Cited by 57
“GDF15 may suppress hepcidin mRNA expression in hepatocytes [24] and promote normal erythroid differentiation [27].”
BackgroundKong, W.-N., Gao, G., & Chang, Y.-Z. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-19 · Cited by 54
“In cultured hepatocytes, high level of GDF15 has also been found to suppress hepcidin expression [86].”
BackgroundSasaki, Y., Noguchi‐Sasaki, M., Yasuno, H., Yorozu, K., & Shimonaka, Y. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1217-4 · Cited by 59
Bone morphogenetic protein and bone metastasis, implication and therapeutic potential
Ye, L., Mason, M. D., & Jiang, W. G. (2010) · Frontiers in bioscience · doi:10.2741/3725 · Cited by 54
“Based on literature published BMP2(13); BMP3(13); BMP4(13); BMP5(14); BMP6(14); BMP7(16); BMP8A(313); BMP8B(314); BMP10(315); BMP15(316); GDF1(15, 317, 318); GDF2(319); GDF3(320-322); GDF5(323); GDF6(324); GDF7(325); GDF8(326); GDF9(320);GDF10(327); GDF11(328); GDF15(329-331).”
Crosstalk between Iron Metabolism and Erythropoiesis
Li, H., & Ginzburg, Y. Z. (2010) · Advances in Hematology · doi:10.1155/2010/605435 · Cited by 59
“These findings suggest that increased serum GDF15 may be the factor through which ineffective erythropoiesis and/or increased erythroid precursor apoptosis influence hepcidin expression and iron homeostasis in β-thalassemic patients [66].”
BackgroundCui, R., Gale, R. P., Zhu, G., Xu, Z., Qin, T., Zhang, Y., Huang, G., Li, B., Fang, L., Zhang, H., et al. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.01.016 · Cited by 51
“GDF15 has been identified as a negative regulator of hepcidin expression in patients with βthalassaemia and in isolated human hepatocytes [7].”
BackgroundInfluentialIron overload and chelation therapy in myelodysplastic syndromes
Temraz, S. N., Santini, V., Musallam, K. M., & Taher, A. T. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.01.006 · Cited by 56
Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone
Chung, B., Verdier, F., Matak, P., Deschemin, J., Mayeux, P., & Vaulont, S. (2010) · The FASEB Journal · doi:10.1096/fj.09-152561 · Cited by 51
“Recently, studies in -thalassemia patients, in which erythropoietic drive is greatly elevated, have helped identify two such putative erythroid regulators, GDF-15 and twisted gastrulation (TWSG1), which may contribute to dysregulated iron homeostasis in thalassemia syndromes (32, 33).”
BackgroundFactors influencing disease phenotype and penetrance in HFE haemochromatosis
Rochette, J., Gac, G. L., Lassoued, K., Férec, C., & Robson, K. (2010) · Human Genetics · doi:10.1007/s00439-010-0852-1 · Cited by 58
“GDF15, TMPRSS6 and TWSG1 have all been shown to negatively regulate hepcidin, and so, any polymorphisms in these genes might well influence iron loading and hence iron stores (Tanno et al. 2007, 2009; Du et al. 2008; Silvestri et al. 2008).”
BackgroundYun, S., & Vincelette, N. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.02.006 · Cited by 63
“[53] Tanno T, Bhanu NV, Oneal PA, et al.”
BackgroundUlirsch, J. C., Lacy, J. N., An, X., Mohandas, N., Mikkelsen, T. S., & Sankaran, V. G. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004890 · Cited by 48
“GDF15 has been suggested to play an important role in the regulation of iron homeostasis as a result of changes in the extent and effectiveness of erythropoiesis [49].”
BackgroundIron dysregulation in beta-thalassemia
Leecharoenkiat, K., Lithanatudom, P., Sornjai, W., & Smith, D. R. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.07.035 · Cited by 59
“It has been suggested that the production of growth differentiation factor 15 (GDF15) [28,85] and possibly other proteins, such as twisted-gastrulation 1 (TWSG1) [29] , contributes to the inhibition of hepcidin synthesis and thus promotes iron Beta-thalassemia patients experience anemia mainly from…”
BackgroundInfluentialHao, S., Xiang, J., Wu, D.-C., Fraser, J. W., Ruan, B., Cai, J., Patterson, A. D., Lai, Z.-C., & Paulson, R. F. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000375 · Cited by 54
Zeng, L., Pei, L., Li, C., & Yan, H. (2018) · Current Topics in Anemia · doi:10.5772/intechopen.69048 · Cited by 49
Endocrine and Bone Complications inβ-Thalassemia Intermedia: Current Understanding and Treatment
Inati, A. C., Noureldine, M. H. A., Mansour, A. G., & Abbas, H. A. (2015) · BioMed Research International · doi:10.1155/2015/813098 · Cited by 66
Koren, A., Fink, D. L., Admoni, O., Tenenbaum‐Rakover, Y., & Levin, C. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01342.x · Cited by 52
“Splenectomy 5 (23) 6 (40) 11 (30) 7 (23) 6 (46) 16 (35) NS”
BackgroundChuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression
Gordeuk, V. R., Miasnikova, G. Y., Sergueeva, A. I., Niu, X., Nouraie, M., Okhotin, D. J., Polyakova, L. A., Ammosova, T., Nekhai, S., Ganz, T., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345512 · Cited by 51
Self-citationRegulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency
Finkenstedt, A., Bianchi, P., Theurl, I., Vogel, W., Witcher, D. R., Wroblewski, V. J., Murphy, A. T., Zanella, A., & Zoller, H. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07535.x · Cited by 51
“As GDF15 was reported to counteract the effect of iron overload 790 ª 2008 Blackwell Publishing Ltd, British Journal of Haematology, 144, 789–793 on hepcidin expression in patients with b-thalassaemia (Tanno et al, 2007), we studied serum GDF15 concentrations in patients with PKD.”
BackgroundResultInfluentialVitamin A deficiency modulates iron metabolism via ineffective erythropoiesis
da Cunha, M. D. S. B., Siqueira, E. M. A., Trindade, L. S., & Arruda, S. F. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.05.005 · Cited by 56
“Recent reports suggest that hepcidin expression is suppressed by GDF15 in patients with ineffective erythropoiesis, suggesting that this erythroblast-expressed factor may be responsible for the iron overloading observed in these patients due to hepcidin suppression [49,53,54].”
BackgroundEssential but toxic: Controlling the flux of iron in the body
Anderson, G. J., & Wang, F. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05661.x · Cited by 53
Managing the Dual Nature of Iron to Preserve Health
Silvestri, L., Pettinato, M., Furiosi, V., Volpe, L. B., Nai, A., & Pagani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043995 · Cited by 53
“Several molecules have been proposed as “erythroid regulators”, such as growth differentiation factor 15 (GDF15), a member of the Tumor Growth Factor β family produced and released by erythroblasts in response to EPO stimulation [78], and Twisted Gastrulation Protein Homolog 1 (TWSG1), an antagonist of the BMP pathway…”
BackgroundHepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines
Zhang, X., & Rovin, B. H. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.08.005 · Cited by 48
Function of the hemochromatosis protein HFE: Lessons from animal models
Pantopoulos, K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6893 · Cited by 49
How I manage patients with atypical microcytic anaemia
Camaschella, C. (2013) · British Journal of Haematology · doi:10.1111/bjh.12081 · Cited by 49
“Among signals released from erythroid cells, the transforming growth factor-beta family member GDF15 has been claimed to mediate hepcidin inhibition (Tanno et al, 2007).”
BackgroundChen, Q., Wang, Y., Zhao, M., Hyett, J. A., Costa, F. D. S., & Nie, G. (2016) · Cytokine · doi:10.1016/j.cyto.2016.05.002 · Cited by 51
“In addition, because iron regulates the secretion of GDF15 [30] and iron absorption is increased during pregnancy [31], iron regulation may also contribute to the observed GDF15 serum changes in pregnancy.”
BackgroundZhang, J., Zheng, L., Wang, Z., Pei, H., Hu, W., Nie, J., Shang, P., Li, B., Hei, T. K., & Zhou, G. (2018) · Bone · doi:10.1016/j.bone.2018.10.005 · Cited by 49
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
de Swart, L., Reiniers, C., Bagguley, T., van Marrewijk, C., Bowen, D., Hellström-Lindberg, E., Tatic, A., Symeonidis, A., Huls, G., Cermak, J., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.171884 · Cited by 48
“GDF15 is a protein produced by erythroid precursors and has been reported to be involved in the communication between bone marrow and liver in case of an increased erythroid demand, functioning as a suppressor of hepcidin synthesis, as shown for β-thalassemia.(5,9,22) However, its role in MDS is still a matter of deba…”
ResultGDF-15 in Pulmonary and Critical Care Medicine
Verhamme, F. M., Freeman, C. M., Brusselle, G., Bracke, K. R., & Curtis, J. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0379tr · Cited by 50
“homeostasis, in primary human hepatocytes (a finding not confirmed in mice) (35, 36).”
Background
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.